» Articles » PMID: 22921664

Persistent Hypertension After Adrenalectomy for an Aldosterone-producing Adenoma: Weight As a Critical Prognostic Factor for Aldosterone's Lasting Effect on the Cardiac and Vascular Systems

Overview
Journal J Surg Res
Specialty General Surgery
Date 2012 Aug 28
PMID 22921664
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary aldosteronism caused by an aldosterone producing adrenal tumor/aldosteronoma (APA), is a potentially curable form of hypertension, via unilateral adrenalectomy. Resolution of hypertension (HTN) is not as prevalent after tumor resection, as are the normalization of aldosterone secretion, hypokalemia, and other metabolic abnormalities. Here, we review the immediate and long-term medical outcomes of laparoscopic adrenalectomy in patients with an APA, and attempt to identify any distinctive sex differences in the management of resistant HTN.

Methods: We performed a retrospective review of the prospective adrenal database at the University of Wisconsin between January 2001 and October 2010. Of the 165 adrenalectomies performed, 32 were for the resection of an APA. Patients were grouped according to their postoperative HTN status. Those patients with normal blood pressure (≤120/80 mm Hg) and on no antihypertensive medication (CURE) were compared with those who continued to require medication for blood pressure control (HTN). We evaluated sex, age, body mass index, tumor size, duration of time with high blood pressure, and the differences in systolic and diastolic blood pressure following adrenalectomy. Statistical analysis was performed using Student's t-test. Statistical significance was defined as a P value of <0.05.

Results: We identified 32 patients with an APA based on biochemical and radiographic studies, two patients were excluded, due to missing data. There were 19 males (63%) and 11 (37%) females, with a mean age was 48.3 ± 2.1 y, and mean tumor size was 24 ± 3 mm. Postoperatively, patients required significantly fewer antihypertensive medications (1.5 ± 0.2 versus 3.3 ± 0.3, P < 0.001). Nine patients (31%) had complete resolution of their HTN, requiring no postoperative antihypertensive medication. The only significant difference between the sexes, was a lower body mass index in women (27.6 ± 1.7 versus 33.4 ± 2.1 kg/m(2), P = 0.04). Ninety percent of the cohort had at least a 20 mm Hg decline in their systolic blood pressure postoperatively, placing them in the prehypertensive or normal blood pressure categories. Sixty-six percent of the CURE patients required at least 6 mo for resolution of their HTN. All 20 patients who presented with hypokalemia, had immediate resolution postoperatively and did not require continuance of the preoperative spironolactone or potassium supplementation.

Conclusions: Laparoscopic adrenalectomy for aldosterone producing adenoma results in the normalization of, or more readily manageable blood pressure in 90% of patients, within 6 mo. Metabolic disturbances are immediately corrected with tumor resection. Weight is an important contributing factor in resolving HTN.

Citing Articles

Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response.

Ruiz-Sanchez J, Paja-Fano M, Gonzalez Boillos M, Peris B, Pascual-Corrales E, Garcia Cano A J Clin Endocrinol Metab. 2023; 109(1):e379-e388.

PMID: 37428898 PMC: 10735298. DOI: 10.1210/clinem/dgad400.


Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism.

Arjani S, Bostonian T, Prasath V, Quinn P, Chokshi R J Endocrinol Invest. 2022; 45(10):1899-1908.

PMID: 35612811 DOI: 10.1007/s40618-022-01821-7.


Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism.

Liao H, Wang S, Chan C, Lin Y, Lin P, Ho C Ther Adv Chronic Dis. 2020; 11:2040622320944792.

PMID: 32922714 PMC: 7457632. DOI: 10.1177/2040622320944792.


Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.

Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I J Endocr Soc. 2020; 4(4):bvaa011.

PMID: 32190802 PMC: 7067551. DOI: 10.1210/jendso/bvaa011.


Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism.

BiLiGe W, Wang C, Bao J, Yu D, Min A, Hong Z Medicine (Baltimore). 2019; 98(30):e16611.

PMID: 31348309 PMC: 6708826. DOI: 10.1097/MD.0000000000016611.


References
1.
Obara T, Ito Y, Okamoto T, Kanaji Y, Yamashita T, Aiba M . Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery. 1992; 112(6):987-93. View

2.
Celen O, OBrien M, MELBY J, Beazley R . Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996; 131(6):646-50. DOI: 10.1001/archsurg.1996.01430180072015. View

3.
Young Jr W . Primary aldosteronism: A common and curable form of hypertension. Cardiol Rev. 1999; 7(4):207-14. View

4.
CONN J . Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome, 1954. J Lab Clin Med. 1990; 116(2):253-67. View

5.
Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N . Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008; 371(9628):1921-6. DOI: 10.1016/S0140-6736(08)60834-X. View